Spinal Simplicity’s Chief Strategy Officer Neil P. Dougherty shares how the company is advancing minimally invasive solutions to enhance patient outcomes.
Neil P. Dougherty, chief strategy officer of Spinal Simplicity, discusses the company’s position in the interventional spine and pain market, what the company looks forward to in the future and how it serves patients treated by spine surgeons and interventional pain management physicians.
Click on the following video (17:18 min) to learn more. A link to download a complete transcript of the interview is also provided below.
SmartTRAK: Hi, this is Erin Dorgan with SmartTRAK. I'm here today with Neil Dougherty, chief strategy officer with Spinal Simplicity. Thanks for joining me today, Neil.
Neil P Dougherty: Glad to be here. Thanks, Erin.
You're welcome. Can you share a little bit more about what you do at Spinal Simplicity? I know, based upon your background, you've been in the interventional space for a while. How did you end up here at Spinal Simplicity?
NPD: Well, in a startup you wear a lot of hats. So I came to Spinal Simplicity first as a vice president of sales and then moved over to focus on just business development and more of an offensive role for our expansion. And as the company grew, an opportunity for promotion was there to get to my now title, chief strategy officer.
I have been in the interventional pain space for a long time. Gosh, it's about 15 years now. Started with Medtronic, doing spinal cord stimulators and intrathecal pumps--just over five years there. Then went over to Vertiflex in that startup campaign bought by Boston Scientific and only a year of integration there after that purchase.
And then how could you forget? When the whole world basically shut down during COVID, I was kind of losing my mind a little bit. I had a couple phone calls from some doctors and also Todd Moseley, the CEO of Spinal Simplicity, and founder. And I started learning more about Spinal Simplicity. I saw their main product, Minuteman. I was like, ‘This is where I need to be.’
Okay. So speaking of Minuteman, and obviously with your background, Boston Scientific recently discontinued Vertiflex Superion. Do you think that is an opportunity for Spinal Simplicity and Minuteman to explore those customers? Or how would you describe that?
NPD: I think so. I'd like to describe it as just an acceleration to where most of those customers were probably going to graduate anyway. Superion was a great idea. I mean, it wasn't even a Vertiflex idea. This is, indirect decompression has been a great studied spine idea for a long time and it certainly wasn't the first ISP out there, but the aim is ...
Click the button below to download and read the complete transcript of SmartTRAK's interview with Neil P. Dougherty, CSO of Spinal Simplicity conducted by Erin Dorgan, SmartTRAK Sr Analyst, Spine & Bone Replacement.